BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27417579)

  • 1. Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.
    Gong Y; Fu Z; Edin ML; Liu CH; Wang Z; Shao Z; Fredrick TW; Saba NJ; Morss PC; Burnim SB; Meng SS; Lih FB; Lee KS; Moran EP; SanGiovanni JP; Hellström A; Hammock BD; Zeldin DC; Smith LE
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1919-27. PubMed ID: 27417579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
    Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
    EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 oxidase 2J inhibition suppresses choroidal neovascularization in mice.
    Gong Y; Tomita Y; Edin ML; Ren A; Ko M; Yang J; Bull E; Zeldin DC; Hellström A; Fu Z; Smith LEH
    Metabolism; 2022 Sep; 134():155266. PubMed ID: 35868524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 2C8 ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--brief report.
    Shao Z; Fu Z; Stahl A; Joyal JS; Hatton C; Juan A; Hurst C; Evans L; Cui Z; Pei D; Gong Y; Xu D; Tian K; Bogardus H; Edin ML; Lih F; Sapieha P; Chen J; Panigrahy D; Hellstrom A; Zeldin DC; Smith LE
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):581-6. PubMed ID: 24458713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin Mediates Dietary Omega-3 Long-Chain Polyunsaturated Fatty Acid Protection Against Choroidal Neovascularization in Mice.
    Fu Z; Liegl R; Wang Z; Gong Y; Liu CH; Sun Y; Cakir B; Burnim SB; Meng SS; Löfqvist C; SanGiovanni JP; Hellström A; Smith LEH
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3862-3870. PubMed ID: 28763559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization.
    Hasegawa E; Inafuku S; Mulki L; Okunuki Y; Yanai R; Smith KE; Kim CB; Klokman G; Bielenberg DR; Puli N; Falck JR; Husain D; Miller JW; Edin ML; Zeldin DC; Lee KSS; Hammock BD; Schunck WH; Connor KM
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):E7545-E7553. PubMed ID: 28827330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agents that bind annexin A2 suppress ocular neovascularization.
    Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
    J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
    PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, inhibits angiogenesis in models of ocular neovascular diseases.
    Oliner JD; Bready J; Nguyen L; Estrada J; Hurh E; Ma H; Pretorius J; Fanslow W; Nork TM; Leedle RA; Kaufman S; Coxon A
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2170-80. PubMed ID: 22410553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of choroidal neovascularization by dietary intake of ω-3 long-chain polyunsaturated fatty acids and lutein in mice.
    Yanai R; Chen S; Uchi SH; Nanri T; Connor KM; Kimura K
    PLoS One; 2018; 13(4):e0196037. PubMed ID: 29694386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases.
    Gong Y; Fu Z; Liegl R; Chen J; Hellström A; Smith LE
    Am J Clin Nutr; 2017 Jul; 106(1):16-26. PubMed ID: 28515072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin.
    Fu Z; Lofqvist CA; Shao Z; Sun Y; Joyal JS; Hurst CG; Cui RZ; Evans LP; Tian K; SanGiovanni JP; Chen J; Ley D; Hansen Pupp I; Hellstrom A; Smith LE
    Am J Clin Nutr; 2015 Apr; 101(4):879-88. PubMed ID: 25833984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic Profiling of Long-Chain Polyunsaturated Fatty Acid Oxidation in Adults with Retinal Vein Occlusion: A Case-Control Study.
    Ren J; Ren A; Huang Z; Deng X; Jiang Z; Xue Y; Fu Z; Smith LE; Ke M; Gong Y
    Am J Clin Nutr; 2023 Sep; 118(3):579-590. PubMed ID: 37454758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
    Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3/Omega-6 Long-Chain Fatty Acid Imbalance in Phase I Retinopathy of Prematurity.
    Fu Z; Yan W; Chen CT; Nilsson AK; Bull E; Allen W; Yang J; Ko M; SanGiovanni JP; Akula JD; Talukdar S; Hellström A; Smith LEH
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
    Kinose F; Roscilli G; Lamartina S; Anderson KD; Bonelli F; Spence SG; Ciliberto G; Vogt TF; Holder DJ; Toniatti C; Thut CJ
    Mol Vis; 2005 May; 11():366-73. PubMed ID: 15951738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial TWIST1 promotes pathological ocular angiogenesis.
    Li J; Liu CH; Sun Y; Gong Y; Fu Z; Evans LP; Tian KT; Juan AM; Hurst CG; Mammoto A; Chen J
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8267-77. PubMed ID: 25414194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization.
    Yanai R; Mulki L; Hasegawa E; Takeuchi K; Sweigard H; Suzuki J; Gaissert P; Vavvas DG; Sonoda KH; Rothe M; Schunck WH; Miller JW; Connor KM
    Proc Natl Acad Sci U S A; 2014 Jul; 111(26):9603-8. PubMed ID: 24979774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.